Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Perrillo

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Seminars in Liver Disease|July 15, 2000
Case studies of the hepatitis B patient: a panel discussionJ M Vierling, L W Teperman, J R Lake, et al.
Clinical Transplantation|March 21, 2002
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary resultsG E Loss, A L Mason, J Blazek, et al.
Annals of Internal Medicine|July 15, 1988
Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trialR P Perrillo, F G Regenstein, M G Peters, et al.
Gastroenterology|February 1, 1995
Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatmentN V Naoumov, M G Thomas, A L Mason, et al.
Hepatology (Baltimore, Md.)|June 1, 1994
Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patientsG L Davis, J Y Lau, M S Urdea, et al.
American Journal of Clinical Pathology|November 1, 1995
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assayD A Hendricks, B J Stowe, B S Hoo, et al.
Journal of Viral Hepatitis|January 1, 1994
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy GroupG L Davis, K Lindsay, J Albrecht, et al.
Journal of Hepatology|January 1, 1990
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy GroupG L Davis, L A Balart, E R Schiff, et al.
The New England Journal of Medicine|November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialG L Davis, L A Balart, E R Schiff, et al.
Gastroenterology|July 1, 1993
Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitisA L Mason, M Wick, H M White, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Seminars in Liver Disease|July 15, 2000
Case studies of the hepatitis B patient: a panel discussionJ M Vierling, L W Teperman, J R Lake, et al.
Clinical Transplantation|March 21, 2002
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary resultsG E Loss, A L Mason, J Blazek, et al.
Annals of Internal Medicine|July 15, 1988
Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trialR P Perrillo, F G Regenstein, M G Peters, et al.
Gastroenterology|February 1, 1995
Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatmentN V Naoumov, M G Thomas, A L Mason, et al.
Hepatology (Baltimore, Md.)|June 1, 1994
Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patientsG L Davis, J Y Lau, M S Urdea, et al.
American Journal of Clinical Pathology|November 1, 1995
Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assayD A Hendricks, B J Stowe, B S Hoo, et al.
Journal of Viral Hepatitis|January 1, 1994
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy GroupG L Davis, K Lindsay, J Albrecht, et al.
Journal of Hepatology|January 1, 1990
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy GroupG L Davis, L A Balart, E R Schiff, et al.
The New England Journal of Medicine|November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialG L Davis, L A Balart, E R Schiff, et al.
Gastroenterology|July 1, 1993
Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitisA L Mason, M Wick, H M White, et al.
Pageof 10